March 9, 2018
Luminor Medical Technologies (TSXV:LMT), further to the acquisition of RISE Research Inc., announced today that it changed its corporate name...
January 24, 2018
Intellipharmaceutics International (Nasdaq:IPCI) a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled- and targeted-release...
December 13, 2017
Here are the five top stories that caught the attention of our investor audience in the pharmaceutical business during 2017.
September 1, 2017
Intellipharmaceutics International announced the appointment of a new Chief Financial Officer.
April 10, 2017
Intellipharmaceutics International is facing legal action related to a patent infringement case from Purdue Pharma.
March 20, 2017
INN sat down with Intellipharmaceutics' CEO Dr. Isa Odidi, to talk about its abuse deterrent technologies and product pipeline.
February 10, 2017
TORONTO, Feb. 10, 2017 (GLOBE NEWSWIRE) — Intellipharmaceutics International Inc. (NASDAQ:IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing...